Divya Keethy1, Christine Mrakotsky, Eva Szigethy. 1. aUniversity of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania bDepartment of Psychiatry, Boston Children's Hospital, Boston, Massachusetts cDepartment of Psychiatry, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Abstract
PURPOSE OF REVIEW: Depression in pediatric inflammatory bowel disease is increasingly recognized to be a heterogeneous condition with diverse underlying predisposing and precipitating factors. Although there is a growing awareness regarding the benefits of integrating behavioral health into medical care, the way psychiatric treatments can best target different aspects of depression and related dysfunction has not been systematically explored. RECENT FINDINGS: This review discusses neurobiological risk factors for depression in inflammatory bowel disease including inflammation, associated anti-inflammatory treatment with corticosteroids, pain, and sleep disturbance, as well as psychosocial factors including reactions to illness, illness perception, and disease and environmental stressors with an emphasis on how these factors can influence treatment decisions. Empirically supported psychosocial and psychopharmacological interventions are discussed within this context. SUMMARY: Understanding the diverse pathways that can lead to depression in youths with inflammatory bowel disease can lead to the development of more targeted interventions and better integration of psychosocial care into the medical treatment of inflammatory bowel disease.
PURPOSE OF REVIEW: Depression in pediatric inflammatory bowel disease is increasingly recognized to be a heterogeneous condition with diverse underlying predisposing and precipitating factors. Although there is a growing awareness regarding the benefits of integrating behavioral health into medical care, the way psychiatric treatments can best target different aspects of depression and related dysfunction has not been systematically explored. RECENT FINDINGS: This review discusses neurobiological risk factors for depression in inflammatory bowel disease including inflammation, associated anti-inflammatory treatment with corticosteroids, pain, and sleep disturbance, as well as psychosocial factors including reactions to illness, illness perception, and disease and environmental stressors with an emphasis on how these factors can influence treatment decisions. Empirically supported psychosocial and psychopharmacological interventions are discussed within this context. SUMMARY: Understanding the diverse pathways that can lead to depression in youths with inflammatory bowel disease can lead to the development of more targeted interventions and better integration of psychosocial care into the medical treatment of inflammatory bowel disease.
Authors: Heba N Iskandar; Benjamin Cassell; Navya Kanuri; C Prakash Gyawali; Alexandra Gutierrez; Themistocles Dassopoulos; Matthew A Ciorba; Gregory S Sayuk Journal: J Clin Gastroenterol Date: 2014 May-Jun Impact factor: 3.062
Authors: Lori A Zimmerman; Arvind I Srinath; Alka Goyal; Athos Bousvaros; Peter Ducharme; Eva Szigethy; Samuel Nurko Journal: Inflamm Bowel Dis Date: 2013 Mar-Apr Impact factor: 5.325
Authors: David B Nicholas; Sylvia R Swan; Ted J Gerstle; Theresa Allan; Anne Marie Griffiths Journal: Health Qual Life Outcomes Date: 2008-12-17 Impact factor: 3.186
Authors: Perseus V Patel; Matthew S Pantell; Melvin B Heyman; Sofia Verstraete Journal: J Pediatr Gastroenterol Nutr Date: 2019-11 Impact factor: 2.839
Authors: Clayton S Edwards; Caroline M Roberts; Marissa N Baudino; Nathan L Basile; Kaitlyn L Gamwell; Noel J Jacobs; Jeanne Tung; John E Grunow; Larry L Mullins; John M Chaney Journal: J Clin Psychol Med Settings Date: 2022-06-06
Authors: Gertrude van den Brink; Luuk Stapersma; Hanan El Marroun; Jens Henrichs; Eva M Szigethy; Elisabeth Mwj Utens; Johanna C Escher Journal: BMJ Open Gastroenterol Date: 2016-03-02
Authors: Smaranda Diaconescu; Silvia Strat; Gheorghe G Balan; Carmen Anton; Gabriela Stefanescu; Ileana Ioniuc; Ana Maria Alexandra Stanescu Journal: Medicina (Kaunas) Date: 2020-08-23 Impact factor: 2.430
Authors: Pamela Qualter; Alison Rouncefield-Swales; Lucy Bray; Lucy Blake; Steven Allen; Chris Probert; Kay Crook; Bernie Carter Journal: Qual Life Res Date: 2020-09-30 Impact factor: 3.440